Christopher George

1.8k total citations · 1 hit paper
19 papers, 1.3k citations indexed

About

Christopher George is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Christopher George has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Christopher George's work include Renal cell carcinoma treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Renal and related cancers (3 papers). Christopher George is often cited by papers focused on Renal cell carcinoma treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Renal and related cancers (3 papers). Christopher George collaborates with scholars based in United States, United Kingdom and Sweden. Christopher George's co-authors include Gina Brown, Uday Patel, Fiona Taylor, Nicola Bees, Ashley Guthrie, Everett E. Vokes, David Sebag‐Montefiore, Richard J. Heald, Lennart Blomqvist and Ian Swift and has published in prestigious journals such as Journal of Clinical Oncology, ACS Nano and The Journal of Physical Chemistry B.

In The Last Decade

Christopher George

19 papers receiving 1.2k citations

Hit Papers

Magnetic Resonance Imaging–Detected Tumor Response for Lo... 2011 2026 2016 2021 2011 100 200 300 400

Peers

Christopher George
Jerrold B. Teitcher United States
Lester Peters Australia
O. Thetter Germany
Binglin Yue United States
Vanessa Bolejack United States
Jerrold B. Teitcher United States
Christopher George
Citations per year, relative to Christopher George Christopher George (= 1×) peers Jerrold B. Teitcher

Countries citing papers authored by Christopher George

Since Specialization
Citations

This map shows the geographic impact of Christopher George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher George more than expected).

Fields of papers citing papers by Christopher George

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher George. The network helps show where Christopher George may publish in the future.

Co-authorship network of co-authors of Christopher George

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher George. A scholar is included among the top collaborators of Christopher George based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher George. Christopher George is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mulcahy, Mary F., Sheetal Kircher, Christopher George, et al.. (2023). Enhancement and Implementation of a Health Information Technology Module to Improve the Discrete Capture of Cancer Staging in a Diverse Regional Health System. JCO Oncology Practice. 19(10). e957–e966. 1 indexed citations
2.
Mina, Alain, Reem Karmali, Mary F. Mulcahy, et al.. (2022). Outcomes of Cancer Patients with COVID-19 in a Hospital System in the Chicago Metropolitan Area. Cancers. 14(9). 2209–2209. 2 indexed citations
3.
KuKanich, Kate S., Christopher George, James K. Roush, et al.. (2020). Effects of low-dose meloxicam in cats with chronic kidney disease. Journal of Feline Medicine and Surgery. 23(2). 138–148. 22 indexed citations
4.
Patel, Uday, Lennart K. Blomqvist, Fiona Taylor, et al.. (2012). MRI After Treatment of Locally Advanced Rectal Cancer: How to Report Tumor Response—The MERCURY Experience. American Journal of Roentgenology. 199(4). W486–W495. 159 indexed citations
5.
George, Christopher, Igal Szleifer, & Mark A. Ratner. (2012). Multiple-Time-Scale Motion in Molecularly Linked Nanoparticle Arrays. ACS Nano. 7(1). 108–116. 9 indexed citations
6.
Patel, Uday, Fiona Taylor, Lennart Blomqvist, et al.. (2011). Magnetic Resonance Imaging–Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience. Journal of Clinical Oncology. 29(28). 3753–3760. 480 indexed citations breakdown →
7.
Koh, Dow‐Mu, Christopher George, Louis Temple, et al.. (2010). Diagnostic Accuracy of Nodal Enhancement Pattern of Rectal Cancer at MRI Enhanced With Ultrasmall Superparamagnetic Iron Oxide: Findings in Pathologically Matched Mesorectal Lymph Nodes. American Journal of Roentgenology. 194(6). W505–W513. 68 indexed citations
8.
George, Christopher, Hidehiro Yoshida, William A. Goddard, Seung Soon Jang, & Yong‐Hoon Kim. (2008). Charge Transport through Polyene Self-Assembled Monolayers from Multiscale Computer Simulations. The Journal of Physical Chemistry B. 112(47). 14888–14897. 11 indexed citations
9.
Seiwert, Tanguy Y., Philip P. Connell, Ann M. Mauer, et al.. (2007). A Phase I Study of Pemetrexed, Carboplatin, and Concurrent Radiotherapy in Patients with Locally Advanced or Metastatic Non–Small Cell Lung or Esophageal Cancer. Clinical Cancer Research. 13(2). 515–522. 67 indexed citations
11.
Seiwert, Tanguy Y., Ann M. Mauer, P. C. Hoffman, et al.. (2005). A phase I dose-escalating study of combination pemetrexed-based chemotherapy and concomitant radiotherapy for locally advanced or metastatic non-small cell lung or esophageal cancer. Journal of Clinical Oncology. 23(16_suppl). 7062–7062. 11 indexed citations
12.
George, Christopher & Walter M. Stadler. (2003). The Role of Systemic Chemotherapy in the Treatment of Kidney Cancer. Cancer treatment and research. 116. 173–182. 11 indexed citations
13.
Stadler, Walter M., Dezheng Huo, Christopher George, et al.. (2003). Prognostic Factors for Survival With Gemcitabine Plus 5-fluorouracil Based Regimens for Metastatic Renal Cancer. The Journal of Urology. 170(4 Part 1). 1141–1145. 53 indexed citations
14.
Tschoep, Katharina, Thomas C. Manning, Helena Harlin, et al.. (2003). Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based vaccines. Journal of Leukocyte Biology. 74(1). 69–80. 18 indexed citations
15.
Davis, Nancy B., David Taber, Rafat Ansari, et al.. (2003). Phase II Trial of PS-341 in Patients With Renal Cell Cancer: A University of Chicago Phase II Consortium Study. Journal of Clinical Oncology. 22(1). 115–119. 114 indexed citations
16.
17.
Rudin, Charles M., Gregory A. Otterson, Ann M. Mauer, et al.. (2002). A pilot trial of G3139, a bcl-2 antisense oligonucleotide,and paclitaxel in patients with chemorefractory small-cell lung cancer. Annals of Oncology. 13(4). 539–545. 116 indexed citations
18.
George, Christopher, Ann M. Mauer, S Krauß, et al.. (2001). A Phase I Trial of the Oral Platinum Analogue JM216 with Concomitant Radiotherapy in Advanced Malignancies of the Chest. Investigational New Drugs. 19(4). 303–310. 17 indexed citations
19.
Birch, Robert, B Hazelton, Kurt W. Tauer, et al.. (1992). Peripheral Blood Stem Cell Mobilization by Chemotherapy With and Without Recombinant Human Granulocyte Colony-Stimulating Factor. Journal of Hematotherapy. 1(4). 317–327. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026